MMP-7 as a Potential Marker of Cardiovascular Complications in Patients with Chronic Kidney Disease (CKD)

被引：8
作者：
Musial, Kinga [1 ]
Zwolinska, Danuta [1 ]
机构：
[1] Wroclaw Med Univ, Dept Pediat Nephrol, Wroclaw, Poland
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2012年 / 111卷 / 02期
关键词：
D O I：
10.1111/j.1742-7843.2012.00898.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：73 / 74
页数：2
相关论文
共 5 条
  • [1] Imbalanced Matrix Metalloproteinases in Cardiovascular Complications of End-Stage Kidney Disease: A Potential Pharmacological Target
    Marson, Bernardo P.
    Poli de Figueiredo, Carlos E.
    Tanus-Santos, Jose E.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2012, 110 (05) : 409 - 415
  • [2] Matrix Metalloproteinase (MMP)-2 Genetic Variants Modify the Circulating MMP-2 Levels in End-Stage Kidney Disease
    Marson, Bernardo P.
    Lacchini, Riccardo
    Belo, Vanessa
    Dickel, Samantha
    da Costa, Bartira P.
    Poli de Figueiredo, Carlos E.
    Tanus-Santos, Jose E.
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2012, 35 (03) : 209 - 215
  • [3] Matrix metalloproteinases and soluble Fas/FasL system as novel regulators of apoptosis in children and young adults on chronic dialysis
    Musial, Kinga
    Zwolinska, Danuta
    [J]. APOPTOSIS, 2011, 16 (07) : 653 - 659
  • [4] Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand
    Vargo-Gogola, T
    Crawford, HC
    Fingleton, B
    Matrisian, LM
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2002, 408 (02) : 155 - 161
  • [5] Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome
    Ye, S
    [J]. CARDIOVASCULAR RESEARCH, 2006, 69 (03) : 636 - 645
1